
Uppsala Reports editor
@UMCGlobalSafety
Photo: iStock
Informing patients and the public about risks is tricky. UMC's latest podcast digs into the evidence about what works best, and examines the proper role of health communicators.
People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion.
Alexandra Freeman from the Winton Centre for Risk and Evidence Communication joins the Drug Safety Matters podcast to discuss how to give patients the information they need to decide what's best for them. This fascinating episode challenges assumptions about the role of the narratives in health communication and provides practical, evidence-backed guidance for conveying effective, ethical information about the potential harms and benefits of medicines and vaccines.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Uppsala Monitoring Centre (UMC), the WHO Collaborating Centre for International Drug Monitoring, is pleased to announce the arrival of its new director Peter Hjelmström.
Communications / 06 March 2023
By putting the patient front and centre, UMC is helping countries in the WHO Programme for International Drug Monitoring to promote the safer use of medicines globally.
Communications / 10 November 2022
UMC pays homage to a trailblazer in pharmacovigilance, Dr. Ed Napke
Communications / 14 March 2023